Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q77485569)
Watch
English
Clinical applications of TNF-alpha in cancer
scientific article published on 01 October 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Clinical applications of TNF-alpha in cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
author name string
F J Lejeune
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
C Rüegg
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
D Liénard
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
publication date
1 October 1998
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
published in
Current Opinion in Immunology
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
volume
10
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
page(s)
573-580
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
issue
5
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
cites work
Tumor necrosis factor (TNF).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
First experience and technical aspects of isolated liver perfusion for extensive liver metastasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Isolated perfusion of the kidney with tumor necrosis factor for localized renal-cell carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
VWF release and platelet aggregation in human melanoma after perfusion with TNF alpha
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High serum levels of TNF-α after its administration for isolation perfusion of the limb
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renal function in cancer patients treated with hyperthermic isolated limb perfusion with recombinant tumor necrosis factor-alpha and melphalan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan on pulmonary function assessments
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rapid increase in plasma tenascin-C concentration after isolated limb perfusion with high-dose tumor necrosis factor (TNF), interferon gamma (IFN gamma) and melphalan for regionally advanced tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of isolated limb perfusion with tumour necrosis factor-alpha on the function of monocytes and T lymphocytes in patients with cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thrombocytopenia and complement activation under recombinant TNF alpha/IFN gamma therapy in man.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalan.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980226-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0952-7915(98)80226-4
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
PubMed ID
9794839
1 reference
stated in
Europe PubMed Central
PubMed ID
9794839
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9794839%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit